Keller, MD, PhD GA, Villa Etchegoyen, MD C, Fernandez, PharmD, PhD N, Olivera, PharmD, PhD NM, Quiroga, PharmD, PhD PN, Diez, PhD RA, Di Girolamo, MD, PhD G. Dextropropoxyphene effects on QTc-interval prolongation: Frequency and characteristics in relation to plasma levels. J of Opioid Management [Internet]. 2018 Sep. 1 [cited 2024 Dec. 21];14(5):335-44. Available from: https://wmpllc.org/ojs/index.php/jom/article/view/2013